Clinical Trial Update: FOG-001 in Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

FOG-001 is being studied in a Phase 1/2 trial across multiple locally advanced or metastatic solid tumors and is currently recruiting; indications include color…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adamantinomatous Craniopharyngioma
• Castration-resistant Prostate Cancer
• Colorectal Cancer
• Desmoid Tumor
• Endometrial Carcinoma
• Familial Adenomatous Polyposis
• Hepatocellular Carcinoma
• Prostate Cancer

Drugs mentioned

• FOG-001

Snippet

Sponsor: Parabilis Medicines, Inc. | Conditions: Cancer, Colorectal Cancer | Phase 1, Phase 2 | Status: RECRUITING